Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82